Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis
Olivier Burgy, … , Gerald Burgstaller, Melanie Königshoff
Olivier Burgy, … , Gerald Burgstaller, Melanie Königshoff
Published September 24, 2024
Citation Information: JCI Insight. 2024;9(18):e168889. https://doi.org/10.1172/jci.insight.168889.
View: Text | PDF
Research Article Cell biology Pulmonology

Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis

  • Text
  • PDF
Abstract

Idiopathic pulmonary fibrosis (IPF) is a lethal chronic lung disease characterized by aberrant intercellular communication, extracellular matrix deposition, and destruction of functional lung tissue. While extracellular vesicles (EVs) accumulate in the IPF lung, their cargo and biological effects remain unclear. We interrogated the proteome of EV and non-EV fractions during pulmonary fibrosis and characterized their contribution to fibrosis. EVs accumulated 14 days after bleomycin challenge, correlating with decreased lung function and initiated fibrogenesis in healthy precision-cut lung slices. Label-free proteomics of bronchoalveolar lavage fluid EVs (BALF-EVs) collected from mice challenged with bleomycin or control identified 107 proteins enriched in fibrotic vesicles. Multiomic analysis revealed fibroblasts as a major cellular source of BALF-EV cargo, which was enriched in secreted frizzled related protein 1 (SFRP1). Sfrp1 deficiency inhibited the activity of fibroblast-derived EVs to potentiate lung fibrosis in vivo. SFRP1 led to increased transitional cell markers, such as keratin 8, and WNT/β-catenin signaling in primary alveolar type 2 cells. SFRP1 was expressed within the IPF lung and localized at the surface of EVs from patient-derived fibroblasts and BALF. Our work reveals altered EV protein cargo in fibrotic EVs promoting fibrogenesis and identifies fibroblast-derived vesicular SFRP1 as a fibrotic mediator and potential therapeutic target for IPF.

Authors

Olivier Burgy, Christoph H. Mayr, Déborah Schenesse, Efthymios Fousekis Papakonstantinou, Beatriz Ballester, Arunima Sengupta, Yixin She, Qianjiang Hu, Maria Camila Melo-Narvaéz, Eshita Jain, Jeanine C. Pestoni, Molly Mozurak, Adriana Estrada-Bernal, Ugochi Onwuka, Christina Coughlan, Tanyalak Parimon, Peter Chen, Thomas Heimerl, Gert Bange, Bernd T. Schmeck, Michael Lindner, Anne Hilgendorff, Clemens Ruppert, Andreas Güenther, Matthias Mann, Ali Önder Yildirim, Oliver Eickelberg, Anna Lena Jung, Herbert B. Schiller, Mareike Lehmann, Gerald Burgstaller, Melanie Königshoff

×

Figure 4

Sfrp1 deficiency in fibroblast-derived EVs attenuates lung fibrosis in vivo.

Options: View larger image (or click on image) Download as PowerPoint

Sfrp1 deficiency in fibroblast-derived EVs attenuates lung fibrosis in ...
(A) General outline of the experiment. EVs were isolated from the conditioned media of primary mouse lung fibroblasts (pmLFs) isolated from mice with genetic deletion of Sfrp1 (Sfrp1–/–) or WT control (Sfrp1+/+). SFRP1 expression was verified by Western blot (left panel). Isolated vesicles were characterized for size by NTA and injected intratracheally in mice previously challenged with bleomycin or control NaCl. E.O.D., every other day. (B) Representative histology of the lung of the above-described mice at D21 after bleomycin exposure. Scale bars indicate 2.5 μm or 100 μm (zoom). (C) Collagen quantification on FFPE lung sections stained with Picrosirius red and visualized under polarized light. Representative observation (n = 10 for BLM+Sfrp1+/+ pmLF-EVs and n = 9 BLM+Sfrp1–/– pmLF-EVs, left panel. Scale bar = 100 μm) and quantification (right panel) are shown. Statistical analysis by nonparametric Mann-Whitney. Each point represents 1 mouse. P values are indicated for each comparison.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts